Phase I Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PTK787/ZK 222584 in Patients With Advanced Cancer
J Clin Oncol. 2005 May 2; [Epub ahead of print]
PMID: 15867205
This drug, though only in Phase I testing at this stage, could potentially be useful against GIST in the future if it performs well in Phase II trials. It is active against c-kit as well as angiogenic targets.
Entrez PubMed

